Loading clinical trials...
Loading clinical trials...
Cryotherapy as Prophylaxis Against Oral Mucositis After High-dose Melphalan and Autologous Stem Cell Transplantation for Myeloma: a Randomised, Open-label, Phase 3, Non-inferiority Trial Comparing Two and Seven Hours of Cryotherapy.
Conditions
Interventions
cryotherapy
Start Date
March 1, 2014
Primary Completion Date
December 1, 2018
Completion Date
December 30, 2018
Last Updated
October 15, 2018
NCT07249528
NCT06215118
NCT06679101
NCT05969860
NCT06870760
NCT06057402
Lead Sponsor
Sahlgrenska University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions